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Monograph
Human serum is contaminated with numer-
ous manufactured chemicals released into the
environment during past decades (Arctic
Monitoring and Assessment Programme
2003). Several xenobiotic compounds have
weak agonistic or antagonistic actions on
steroid receptors in in vitro assays (Bonefeld-
Jorgensen 2004; Sohoni and Sumpter 1998)
and in animal models (Gray 1998). The estro-
gen receptor (ER), androgen receptor (AR),
and aryl hydrocarbon receptor (AhR) are
expressed throughout the male genital tract,
and sex hormone signaling plays a pivotal role
for development and regulation of male repro-
ductive function (Hess 2003; Holdcraft and
Braun 2004; Schultz et al. 2003). Effects on
male reproductive organs or reproductive
function in adult rats have been observed after
exposure to weak xenohormones such as poly-
chlorinated biphenyl (PCB) (Hsu et al. 2003),
dichlorodiphenyltrichloroethane (DDT) (Ben
Rhouma et al. 2001), and polychlorinated
dibenzo-p-dioxins (Chahoud et al. 1992; Gray
et al. 1995; Simanainen et al. 2004). Also in
humans, exposure to chemical compounds
with endocrine-disrupting properties has been
suggested to be related to the apparent decline
in semen quality (Swan et al. 2003). However,
it remains unknown whether the low-level
exposure to xenohormones that virtually all
humans experience has implications for repro-
ductive health (Safe 2000; Sharpe and Irvine
2004; Storgaard et al. 2006; Toft et al. 2004). 
In large-scale epidemiologic studies
addressing health risks related to hormonal
active xenobiotics, it is practically and econom-
ically unfeasible to measure serum levels of
more than a few compounds. It is of consider-
able interest that techniques have been devel-
oped to examine the xenobiotic activity of sex
hormone receptors in serum fractions free of
endogenous hormones (Fernandez et al. 2004;
Hjelmborg et al. 2006; Rasmussen et al.
2003). Thus it has become possible to examine
human health outcomes in relation to the
integrated receptor activity of hundreds of
xenobiotics that are found in human serum. 
This article is to our knowledge the first
report of semen quality in relation to xeno-
hormone and AhR activity. We report cross-
sectional relations of serum xenobiotic
receptor activities and semen quantity and
quality in four geographically different study
groups that were selected to obtain high
contrast in body burdens of PCBs and the
main DDT metabolite dichlorodiphenyl-
dichloro-ethylene (p,p´- DDE) (Toft et al.
2005a). 
Materials and Methods
We addressed pregnant couples in 19 towns
and settlements all over Greenland, in
Warsaw (Poland), and in Kharkiv (Ukraine).
Pregnant women and their partners were con-
secutively enrolled during antenatal visits.
Moreover, Swedish fishermen were enrolled
separately and independent of current preg-
nancy. Altogether 798 men provided a fresh
semen sample; the percentage of semen
providers relative to all men who were encour-
aged to deliver a semen sample was 79% in
Greenland (201 men), 7% in Sweden (191
men), 29% in Warsaw (198 men), and 33%
in Kharkiv (208 men). Blood samples were
collected from the participating men within 1
week of the semen sample collection, except
for a subgroup of 116 men from Greenland,
who had their blood sample collected up to 1
year in advance. Venous blood samples were
collected in 10-mL vacuum tubes; and after
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BACKGROUND: Semen quality in humans may be inﬂuenced by exposure to endocrine-disrupting
compounds. 
OBJECTIVES: We analyzed associations between semen characteristics and serum xenoestrogen
receptor (XER), xenoandrogen receptor (XAR), and aryl hydrocarbon receptor (AhR) transactivity.
XER and XAR activity were measured in serum samples cleared for endogenous steroid hormones
and AhR activity in raw lipophilic serum extracts free of proteins. 
RESULTS: All together, 319 men from Warsaw (Poland), Greenland, Kharkiv (Ukraine), and
Sweden provided semen and blood samples. No strong and consistent associations between xenobi-
otic activity and semen quality measures were observed in the four populations. However, when the
data were combined across populations sperm concentration increased 40% per unit increase in
XER activity [95% conﬁdence interval (CI), 1–79%] in the subgroup with XER activity below the
reference level. Among subjects with XER activity above the reference level an increase of 14%
(95% CI, 2–28%) was found. Furthermore, an increase of 10% motile sperm per unit increase in
XER activity below reference level (95% CI, 0.2–20) was found. We are unable to exclude that the
associations are chance ﬁndings.
CONCLUSION: Alteration of XER, XAR, or AhR transactivity within the range found in serum from
the general European and Inuit population seems not to markedly deteriorate sperm cell concentra-
tion, motility, or morphology in adult men. 
KEY WORDS: androgen receptor, aryl hydrocarbon receptor, CALUX, endocrine disruption,
estrogen receptor, human, sperm. Environ Health Perspect 115(suppl 1):15–20 (2007).
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centrifugation the serum samples were stored
at –80°C until analysis. The local ethics com-
mittee in each of the four participating coun-
tries approved the study, and each participant
gave written informed consent before the
study. Details of study design, selection of
populations, and data collection have been
published previously (Toft et al. 2005a).
Receptor-mediated chemical-activated
luciferase gene expression (CALUX) assays of
serum extracts were performed in a subset of
men who provided semen samples. A total of
365 men were available with one, two, or all
three receptor activity values; these included
262 subjects for the AR assay, 338 for the
AhR assay, and 358 for the ER assay. Due to
the limited amount of serum available, not all
receptor assays were performed on each sam-
ple. Data on both xenobiotic activity and
semen quality were available from 319 men.
Characteristics of the study groups are pro-
vided in Table 1. The 319 men did not differ
significantly from the remaining 479 men
delivering a semen sample regarding sperm
concentration, motility, morphology, age, or
period of abstinence before collection of the
semen sample (data not shown). 
Measurements of xenobiotic receptor
activity in serum. For estrogenic and andro-
genic activity determination, the serum frac-
tion (F1) containing persistent organochlorine
pollutants (POPs) and free of endogenous
estrogens and androgens was obtained by
solid phase extraction–high performance liq-
uid chromatography (SPE-HPLC) extraction.
SPE was carried out using Oasis HLB
(hydrophilic-lipophilic balance) extraction
cartridges (vol 6 mL; 500 mg HLB sorbent;
Waters, Milford, MA, USA). Extracted com-
pounds were collected using a VAC ELUT
SPS 24 vacuum manifold (Varian, Harbor
City, CA, USA). The HPLC system consisted
of an Alliance 2695 separations module with
a 300-µL injection loop, equipped with a
2996 Photodiode Array Detector and a
Fraction Collector II (Waters). Separation
was performed on a Spherisorb Si 60 analyti-
cal column 250 × 4.6 mm inner diameter, 5
µm particle size (Waters) as described by
Hjelmborg et al. (2006).
Extraction of lipophilic POPs from serum
to be tested for AhR activity was performed
by ethanol and hexane followed by cleaning
on a Florisil + sodium sulfate column (Ayotte
et al. 2005), at Le Centre de Toxicologie,
Sante Foy, Quebec, Canada. 
Measurements of the xenobiotic-induced
receptor activities are described in detail by
Bonefeld-Jorgensen et al. (2006), Krüger et al.
(2007), and Long et al. (2006). For the estro-
genic, the androgenic, and the AhR activity
assays, all samples were tested in triplicate in
two sets of tests designed to test the basal
response on the receptor assay and the response
when a physiologic level of the respective lig-
and is present, respectively. The test of basal
xenobiotic activity of the serum extract alone
[termed XER (xenoestrogen receptor activity),
XAR (xenoandrogen receptor activity), and
AhR activity] was designed to test primarily for
agonistic effects, but if the response on the
assay was below the reference level (response of
the solvent control) an antagonistic effect is
indicated. On the other hand, the test for
activity when the active ligands [17β-estradiol
(E2), methyltrienolone (R1881), or 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD)] were
present in a concentration giving 40–50% of
maximum induction (termed XERcomp,
XARcomp, and AhRcomp) was designed to
test primarily for antagonistic effects; but if
Table 1. Characteristics of samples with measures of semen quality and at least one of the xenohormone assays.
Characteristic Warsaw, Poland (n = 83) Greenland (n = 54) Kharkiv, Ukraine (n = 86) Fishermen, Sweden (n = 96)
Outcomes 
Sperm concentration × 106/mL [median (5th–95th)]  59 (8–241) 48 (11–152) 56 (17–159) 53 (9–192)
Total sperm count × 106/mL [median (5th–95th)]  190 (19–1,310) 160 (25–650) 170 (35–750) 160 (15–480)
Volume [mL; median (5th–95th)] 3.8 (1.3–7.2) 3.0 (1.2–7.2) 3.1 (1.3–7.9) 2.8 (0.8–7.2)
Percent of A + B motile [mean (5th–95th)] 56 (0–85) 50 (19–79) 57 (19–88) 57 (15–89)
Percent of normal morphology [median (5th–95th)] 6 (2–12) 6 (2–14) 8 (1–16) 7 (1–16)
Exposure markers
XER activity RLU/mL serum [median (5th–95th)]a 3.1 (2.6–5.5) 2.9 (2.3–3.4) 3.2 (2.4–4.0) 3.0 (2.6–4.1)
XER-EEQ [pg/g lipid; median (5th–95th)]b 130 (44–520) —c 140 (80–580) 84 (50–360)
XER competitive activity [RLU/mL serum; median (5th–95th)]d 3.0 (2.5–5.8) 2.7 (2.2–3.3) 2.9 (2.2–3.5) 2.9 (2.0–3.5)
XAR activity [RLU/mL serum; median (5th–95th)]e  3.5 (2.2–6.4) 3.9 (2.6–5.6) 3.6 (2.3–5.0) 3.7 (2.4–5.8)
XAR competitive activity [RLU/mL serum; median (5th–95th)]f  3.0 (1.9–4.1) 4.0 (3.2–6.0) 2.2 (1.3–3.3) 2.9 (2.0–4.6)
AhR activity [RLU/mL serum; median (5th–95th)]g  36 (15–74) 18 (8–62) 27 (15–45) 34 (12–75)
AhR-TEQ [pg/g lipid; median (5th–95th)]b 320 (130–360) 190 (100–600) 330 (180–630) 460 (220–920)
AhR competitive activity [RLU/mL serum; median (5th–95th)]h  6.5 (4.6–8.3) 7.8 (5.8–10.5) 6.7 (1.8–9.8) 6.1 (4.7–8.3)
Potential confounders
Abstinence period days [median (5th–95th)]  3.0 (1–30) 2.5 (0.5–7.0) 3.0 (2.0–7.0) 3.0 (1.0–10.0)
Age [mean years (5th–95th)] 30 (26–38) 30 (20–40) 28 (20–38) 46 (32–62)
Time to analysis [min; mean (5th–95th)]  51 (40–65) 34 (30–50) 36 (25–63) 46 (25–65)
Body mass index [kg/m2; mean (5th–95th)] 26 (20–32) 26 (20–32) 24 (20–30) 26 (22–31)
Season for sperm collection (%)
Spring 5 46 0 53
Summer 24 0 3 28
Fall 30 54 57 19
Winter 41 0 40 0
Fever last three months (%)  11 11 8 4
Urogenital infections (%) 6 85 1 22
Urogenital surgery (%)  2 0 0 1
Spillage yes (%) 10 13 14 16
Current smoking (%) 30 81 71 23
Alcohol consumption [> 21 drinks/week (%)] 4 8 0 NA
NA, not applicable; 5th–95th, range of 5th–95th percentiles. 
aFrequency of samples with ER agonistic effect 21% (Warsaw), 1% (Greenland), 14% (Kharkiv), and 12% (Sweden), respectively. bCalculated on data from samples with agonistic effects
only. Agonistic activity calculated as samples (triplicates) that differed signiﬁcantly from the solvent control values using Student t-test. For details see Bonefeld-Jorgensen et al. (2006),
Long et al. (2006). The equivalence factor for AR (XAR-TEQ) could not be calculated because the weak agonistic responses did not reach the linear range of the R1881 (positive control)
dose–response curve. cOne subject only, data not presented. dFrequency of samples with ER antagonistic effect 7% (Warsaw), 71% (Greenland), 30% (Kharkiv), and 19% (Sweden),
respectively. eFrequency of samples with AR agonistic effect 25% (Warsaw), 35% (Greenland), 26% (Kharkiv), and 34% (Sweden), respectively. fFrequency of samples with AR antagonis-
tic effect 21% (Warsaw), 3% (Greenland), 50% (Kharkiv), and 8% (Sweden), respectively. gFrequency of samples with AhR agonistic effect 100% (Warsaw), 92% (Greenland), 100%
(Kharkiv), and 95% (Sweden), respectively. hFrequency of samples with AhR antagonistic effect 8% (Warsaw), 3% (Greenland), 34% (Kharkiv), and 12% (Sweden), respectively.response on the assay higher than reference
values was observed, an additive or synergistic
effect is indicated. Solvent controls and/or
samples from a pooled serum sample of
Danish men and women were run in parallel
for each assay. Table 2 shows the coefﬁcient of
variations (CVs) between the 3–5 aliquots
from the same serum samples, between solvent
control samples with and without ligand
added in a concentration of 40–50% maxi-
mum activity, and the interassay variability
between pooled serum samples. 
The estrogenic, androgenic, and AhR-
mediated dioxin-like activities were deter-
mined using receptor mediated CALUX
assays. For each assay, a cell line with the
respective receptor and the luciferase reporter
vector was employed as described in previous
research (Bonefeld-Jorgensen et al. 2005,
2006; Krüger et al. 2007; Long et al. 2006).
Brieﬂy, the estrogen response was measured in
the stable transfected MVLN human breast
cancer cell line carrying the estrogen-response-
element-luciferase reporter vector (kindly pro-
vided by M. Pons, INSERM, Montpellier,
France) (Bonefeld-Jorgensen et al. 2006). The
androgen receptor activity was determined in
the Chinese Hamster Ovary cells (CHO-K1)
transiently co-transfected with the MMTV-
Luc reporter vector (kindly provided by R.M.
Evans, Howard Hughes Medical Institute, San
Diego, CA, USA) and the AR expression plas-
mid pSVAR0 (kindly provided by A.O.
Brinkmann, Erasmus University, Rotterdam,
the Netherlands) (Krüger et al. 2007). The
AhR-activity was determined in stable trans-
fected mouse hepatoma cell line Hepa1.12cR
carrying the AhR-luciferase reporter vector
provided by M.S. Denison (University of
California, Davis, CA, USA) (Long et al.
2006). The luciferase activity was measured in
a LUMIstar luminometer (Ramcon,
Denmark) in 96 well plates. The luciferase
activity was calculated as relative light units
(RLU) per microgram cell protein (relative to
the respective solvent control) and ﬁnally pre-
sented as RLU per milliliter serum. The refer-
ence values for the solvent control activity
corresponding to the amount of serum extract
added for the ER and AR assay was 3.14
RLU/mL serum, and 6.67 RLU/mL serum for
the AhR assay. The estradiol equivalence
(XER-EEQ) and TCDD toxic equivalence
(AhR-TEQ) was calculated on samples that
show values signiﬁcantly higher than solvent
control using a standard dose–response curve
of 17β-estradiol and TCDD, respectively. For
details, see Bonefeld-Jorgensen et al. (2006)
and Long et al. (2006). The validity of these
assays has been confirmed by testing the
agonistic or antagonistic response of natural
hormones and a series of chemicals with
endocrine-disrupting activity (Bonefeld-
Jorgensen et al. 2001, 2006; Fernandez et al.
2004; Hjelmborg et al. 2006; Krüger et al.
2007; Long et al. 2006; Pliskova et al. 2005;
Rasmussen et al. 2003).
Collection and analysis of semen samples.
Semen samples were collected by masturba-
tion at the residence or in privacy in a room
at the hospital. The subjects were asked to
abstain from sexual activities for at least
2 days before collecting the sample and to
note the actual abstinence time. If collected at
home, the sample was kept close to the body
to maintain a temperature close to 37°C
when transporting it to the laboratory imme-
diately after collection.
The samples were analyzed for motility
and concentration according to the World
Health Organization (WHO 1999) manual
for basic semen analysis (WHO 1999).
Brieﬂy, for each sperm sample, the sperm con-
centration was determined on two aliquots of
diluted semen samples (1:10 or 1:20) using an
Improved Neubauer Hemacytometer (Paul
Marienfeld, Bad Mergentheim, Germany). If
the difference between the counts on the two
aliquots exceeded 10% of the sum, two new
assessments were made. Using a microscope
mounted with a heated stage (37°C), the
sperm cell motility was determined by count-
ing the proportion of a) fast progressive
sperm; b) slowly progressive sperm; c) local
motile sperm; and d) immotile sperm on 100
sperm within each of two fresh drops of
semen, placed on a preheated (37°C) clean
glass slide, and covered with a cover slip.
All semen samples were analyzed by one
researcher in each country, and all semen ana-
lyzers had been trained in a series of three
workshops held before and during the sample
collection at the Fertility Centre, Malmö
University Hospital, Sweden. This center is
accredited by the European Academy of
Andrology and participates in the Nordic
Association of Andrology and the European
Society of Human Reproduction and
Embryology quality control program. The
median interindividual CV was 8.1% for
sperm concentration assessment and 11.1%
for motility (grade A+B) assessment (Toft
et al. 2005b). 
The morphology of the sperm from all
the countries in this project was determined
centrally by two technicians at the Fertility
Centre, Malmö University Hospital, on
Papanicolaou-stained smears using the WHO
(1999) criteria. 
Statistical analyses. The effects of serum
xenobiotic activities on semen quality are not
easy to predict because of the highly intercon-
nected hormonal regulation of spermatogene-
sis. Thus, a broad strategy for statistical analysis
was employed. Visual inspection of scatterplots
of the crude associations between exposure and
outcome did not indicate any threshold effect
for any of the associations. However, to allow
for analysis of nonmonotonic response across
the whole range of receptor activity, multiple
linear regression analyses were performed in
two receptor activity subgroups showing lower
or higher receptor activity compared with the
reference value of their respective solvent con-
trols, representing agonistic and antagonistic
responses, respectively. If the homogeneity test
did not indicate different associations across
the study populations, we computed common
estimates across all four study populations.
When signiﬁcant associations or heterogeneity
was indicated, the associations in the single
populations were evaluated by Spearman’s cor-
relation analysis. 
Before inclusion in the linear regression
models sperm concentration, percentages of
sperm cells with normal morphology, age, and
abstinence time were transformed by the nat-
ural logarithmic function, which improved
normality and homogeneity of variance, as
indicated by inspection of Q–Q plots. The
percentage of motile sperm cells was not trans-
formed. We decided, a priori, that sperm con-
centration would be adjusted for duration of
sexual abstinence before delivery of the semen
sample and age. Analyses of motility were
restricted to the 95% of samples for which the
analysis was initiated within 60 min after col-
lection. To decide which of the potential con-
founders (listed in Table 1) to adjust for in the
multivariate models, we used the change in
estimate method suggested by Greenland
(1989). None of the β-coefficients were
changed more than 10% when these potential
confounders were included one by one in the
models, except for high alcohol consumption
(> 21 drinks/week). Because of the limited
number of participants with high alcohol con-
sumption and the lack of information on all
the Swedish participants, we made alternative
analyses excluding high alcohol consumers
and achieved similar results. Therefore, the
results are presented without adjustment or
restriction regarding alcohol consumption. All
statistical analyses were performed using SAS
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Table 2. Coefﬁcient of variation in the different xenobiotic assays.
Intra-assay CV  Solvent control  Interassay CV
(between aliquots  Solvent control  + ligand (-comp) (pooled serum samples 
from the same sample) interassay CV interassay CV run in each assay)
XER 5 1 2 13
XAR 11 11 13 31
AhR 11 17 18 —a
aNot analyzed in this assay.software (version 9.1.3; SAS Institute Inc.,
Cary, NC, USA).
Results
The test of homogeneity across populations
indicated country differences in the associa-
tion of sperm concentration to XARcomp
activity, AhR activity, and AhR-TEQ; further-
more, the proportion of normal sperm seemed
to differ among countries in the subgroup
with XARcomp activity < 3.14 (Table 3).
Geographic differences with signiﬁcant associ-
ations between the continuous exposure mark-
ers and semen outcomes were only found for
XARcomp activity and AhR activity, which
showed negative and positive associations,
respectively, to sperm concentration in
Warsaw, but no signiﬁcant associations in the
other populations [see Supplemental Material,
Table 1 (http://www.ehponline.org/docs/
2007/9352/suppl.pdf)]. In all other tested
associations, no indication of heterogeneity
across populations was found, so combined
analysis could be performed. When the data
from the four study groups were combined
(Table 3), a statistical signiﬁcant positive asso-
ciation of sperm concentration and XER activ-
ity was found both below [40% increase per
unit increase in XER activity; 95% conﬁdence
interval (CI), 1 to 79%] and above the refer-
ence level (14%; 95% CI, 2 to 28%), but not
across the whole range of activity (9%; 95% CI,
–1 to 20%). The correlation analysis in the
individual study groups indicated that the
association below reference level was driven
mainly by a positive association in Warsaw,
and the association above reference level was
driven mainly by a positive association in
Sweden [see Supplemental Material, Table 1
(http://www.ehponline.org/docs/2007/
9352/suppl.pdf)]. A scatterplot of the associa-
tion is given in Figure 1A. Furthermore,
sperm motility was positively associated to
XER activity in the subgroup below the refer-
ence level with an increase of 10% motile
sperm per unit increase in XER activity. This
association seemed also to be driven by a posi-
tive association in Warsaw. A scatterplot of
sperm motility and XER activity is given in
Figure 1B.
In the groups stratified at the reference
level, no statistical significant difference in
sperm count, motility, or morphology was
observed between the groups with low or high
receptor activity.
Discussion
The present study suggested a positive associ-
ation of serum xenoestrogen activity and
sperm concentration and motility across the
four study groups. Furthermore, we found
geographic differences in some of the tested
associations, with the most marked effects in
the population from Warsaw. Clearly, the sta-
tistically significant but rather weak associa-
tions must be confirmed in future studies
before any strong conclusion about associa-
tions can be made. 
The positive association of sperm concen-
tration and XER activity found at XER activity
< 3.14 could be caused by adverse effects of
antiestrogenic compounds on sperm count,
which is plausible because of the known essen-
tial role of estrogen receptor function in male
reproduction (Hess 2003). However, the assay
specifically designed to test for competitive
effects did not conﬁrm an association between
effects on this assay and sperm count across
study populations. The positive association of
sperm concentration and XER activity > 3.14,
indicating a stimulating effect of exogenous
estrogenic compounds on sperm counts, is
contrary to the expected, but could be hypoth-
esized to be caused by an antiapoptotic role of
estrogens on germ cells (Pentikainen et al.
2000) or a direct stimulatory effect of estrogens
on spermatogenesis, because ERs are present in
male germ cells (Lambard and Carreau 2005). 
It is well known that there is cross-talk
between ER, AR, and AhR (Morrow et al.
2004; Pascussi et al. 2004) that may lead to
other responses on the receptors in vivo, com-
pared with the ex vivo tests used in the present
study, where the response on the single recep-
tors are tested. This further complicates the
interpretation of the associations of the semen
quality and receptor activities. However, by
evaluating the combined responses on the dif-
ferent receptors we might get closer to net
effects in vivo.
For the group from Warsaw, a predomi-
nantly net estrogenic serum activity was
observed where 21% of the samples had
induced estrogenic effects, and antiestogenic
effects were found only on 7% of the samples,
compared with 1–14% agonistic activity and
19–71% antagonistic activity in the other
study groups (Bonefeld-Jorgensen et al.
2006). This may explain why the associations
of XER activity and sperm count and motility
were found mainly in Warsaw. Whether the
negative association between XARcomp and
semen concentration in Warsaw reflects an
increase of the androgenic activity affecting
the sperm concentration negatively can only
be hypothesized. Similarly, whether the posi-
tive correlation between the AhR activity (and
Toft et al.
18 VOLUME 115 | SUPPLEMENT 1 | December 2007 • Environmental Health Perspectives
Table 3. Analysis of homogeneity across populations and results of multiple linear regressions of semen characteristics on xenobiotic serum activity in the aggre-
gated data set adjusted for study population. 
Log sperm concentrationa Motile spermb Normal sperm cells
p-Value Geometric  p-Value Mean  p-Value Geometric mean 
(homo- mean sperm  (homo- motility (homo- normal sperm 
geneity) β (95% CI) conc (95% CI) geneity) β (95% CI) (95% CI) geneity) β (95% CI) cell (95% CI)
XER activity  0.53 0.09 (–0.01 to 0.20) 53 (48–58) 0.86 1.60 (–1.31 to 4.52) 56 (54–58) 0.91 0.05 (–0.03 to 0.13) 7.0 (6.5–7.5)
XER activity < 3.14 0.17 0.40 (0.01 to 0.79)* 55 (49–62) 0.15 10.2 (0.2 to 20.2)* 56 (52–59) 0.61 –0.06 (–0.36 to 0.24) 6.6 (6.0–7.2)
XER activity ≥ 3.14 0.24 0.14 (0.02 to 0.28)* 51 (43–59) 0.70 1.6 (–2.1 to 5.3) 54 (50–58) 0.87 0.03 (–0.07 to 0.12) 7.6 (6.8–8.5)
XER-EEQ (pg/g lipid)  0.56 < 0.001 (–0.002 to 0.002) 57 (43–75) 0.63 0.02 (–0.03 to 0.07) 54 (47–61) 0.60 0.0006 (–0.0009 to 0.0021) 6.7 (5.5–8.1)
XER competitive activity
c 0.98 –0.08 (–0.22 to 0.05) 54 (49–59) 0.45 –1.7 (–5.4 to 2.0) 56 (54–59) 0.25 –0.009 (–0.11 to 0.09) 7.0 (6.6–7.5)
XERcomp activity < 3.14 0.78 –0.15 (–0.48 to 0.18) 54 (49–60) 0.93 –6.4 (–15.3 to 2.5) 55 (52–58) 0.74 –0.18 (–0.43 to 0.07) 7.1 (6.6–7.7)
XERcomp activity ≥ 3.14 0.92 –0.10 (–0.32 to 0.12) 52 (44–63) 0.53 –4.6 (–10.1 to 0.8) 58 (53–63) 0.99 0.05 (–0.11 to 0.22) 6.9 (6.0–7.9)
XAR activity  0.10 –0.06 (–0.14 to 0.02) 58 (52–64) 0.82 –0.5 (–2.8 to 1.8) 56 (54–59) 0.76 0.01 (–0.05 to 0.07) 7.1 (6.6–7.7)
XAR activity < 3.14 0.62 0.11 (–0.34 to 0.57) 60 (50–73) 0.15 9.4 (–5.2 to 23.9) 59 (53–65) 0.86 0.18 (–0.27 to 0.62) 6.9 (6.0–8.1)
XAR activity ≥ 3.14 0.31 –0.07 (–0.17 to 0.03) 58 (52–65) 0.45 0.2 (–2.7 to 3.1) 55 (51–58) 0.51 0.01 (–0.06 to 0.08) 7.1 (6.5–7.8)
XAR competitive activity
c 0.03 — 58 (52–64) 0.96 0.7 (–3.4 to 4.7) 56 (54–59) 0.62 0.00 (–0.11 to 0.11) 7.1 (6.6–7.7)
XARcomp activity < 3.14 0.39 –0.12 (–0.40 to 0.16) 64 (55–75) 0.74 –3.0 (–11.6 to 5.6) 54 (50–59) 0.03 — 6.9 (6.1–7.7)
XARcomp activity ≥ 3.14 0.92 0.04 (–0.21 to 0.28) 53 (45–63) 0.54 1.9 (–5.4 to 9.1) 58 (52–62) 0.67 0.04 (–0.16 to 0.25) 7.3 (6.4–8.4)
AhR activity 0.03 — 55 (50–61) 0.85 0.07 (–0.07 to 0.20) 56 (53–58) 0.76 0.004 (–0.002 to 0.009) 7.0 (6.6–7.5)
AhR-TEQ (pg/g lipid)  0.001 — 55 (50–61) 0.08 –0.004 (–0.02 to 0.01) 56 (53–59) 0.19 0.0002 (–0.0002 to 0.0005) 7.0 (6.5–7.5)
AhR competitive activity
c 0.94 –0.01 (–0.07 to 0.05) 55 (50–61) 0.77 –0.2 (–1.7 to 1.3) 56 (53–58) 0.98 0.007 (–0.03 to 0.05) 7.0 (6.6–7.5)
AHRcomp activity < 6.67 0.27 –0.04 (–0.17 to 0.09) 54 (47–63) 0.88 0.7 (–8.4 to 9.7) 58 (54–62) 0.43 –0.007 (–0.11 to 0.09) 6.8 (6.2–7.6)
AHRcomp activity ≥ 6.67 0.26 –0.05 (–0.17 to 0.06) 55 (48–63) 0.34 2.2 (–1.0 to 5.3) 53 (50–57) 0.95 –0.03 (–0.30 to 0.23) 7.2 (6.5–7.9)
Abbreviations: —, combined analyses were not performed due to lack of homogeneity across populations; conc, concentration.
aAdjusted for age and abstinence time. bRestricted to samples analyzed within 1 hr after collection. cRLU/mL serum; solvent controls were 3.13 RLU/mL serum (XER and XAR) and
6.67 RLU/mL serum (AhR). *Signiﬁcant associations (p < 0.05). AhR-TEQ) and semen concentration for the
Warsaw study group can be explained by an
increased metabolism of chemicals with
adverse effects on semen concentration can at
this step only be a theory. 
Only three of the 50 associations (6%)
tested by linear regression differed signiﬁcantly
from unity, which is close to the 5% positive
ﬁndings, which were expected to occur under
the null hypothesis of no difference (Table 3).
Therefore, most if not all of the observed asso-
ciations might be chance ﬁndings. 
In the present study we included popula-
tions with both a large within- and between-
population exposure contrast to POPs, which
are known to interfere with ERs, ARs, and
AhRs (Bonefeld-Jorgensen et al. 2001;
Pliskova et al. 2005). The study groups from
Greenland and Sweden represent highly
exposed populations, whereas the other popu-
lations reflect the sort of exposure generally
found in different parts of Europe. Except for
the Swedish ﬁshermen, the included popula-
tions were selected to reﬂect the general popu-
lation in the regions. People with occupational
exposure or people living in accidentally pol-
luted areas may have higher levels of exposure
to POPs or other compounds that may inter-
fere with ER, AR, or AhR.
In the present study, the difference in net
RLU activity in the assays was only 2–3 fold
between samples with low activity (p5) and
high activity (p95), indicating that the actual
contrast in biologic response was limited.
However, the exposure contrast between the
samples with low level (p5) and high level of
calculated ER-EEQ and AhR-TEQ was in the
range of 5- to 10-fold, indicating substantial
differences in the amount of chemicals present
in the samples with low and high activity
(Bonefeld-Jorgensen et al. 2006; Long et al.
2006). The limited contrast in biologic activity
may be one of the reasons for the lack of con-
sistent associations found in the present study. 
Agonistic or antagonistic ER and AR
activity was found in some individuals from
each population, but with large variation
between countries. For example, 71% of the
samples from Greenland showed antagonistic
XERcomp activity, whereas antagonistic
XERcomp activity was found in only 7% of
the samples from Warsaw (Bonefeld-Jorgensen
et al. 2006). However, agonistic AhR activity
was found in almost all of the serum samples
from the included populations in the present
study (97%; Long et al. 2006), and therefore
we would especially expect to detect effects of
this exposure marker across populations if it
was associated with adverse effects on semen
quality. In rats, administration of a single dose
of TCCD in a concentration of 0.05 µg/kg
during gestation reduced offspring sperm
count by 25% (Gray et al. 1997), but adult
exposure to TCDD required a dose of 3 µg/kg
to have effect on male testis (Chahoud et al.
1992). Thus, it seems that male reproductive
function may be affected by AhR-inducing
agents, but it is likely that the most sensitive
period to reproductive disturbances is the fetal
period where small alterations of receptor activ-
ity may be of crucial importance for develop-
ment of reproductive organs. In the present
study we were not able to determine whether
fetal exposure to compounds with effects on
xenobiotic activity is affecting adult semen
quality, but we found no indication that xeno-
biotic AhR agonistic activity was related to
reduced sperm counts or impairment of other
semen characteristics in adult men.
We expected the overall number of sub-
jects included in the present study to be sufﬁ-
cient to detect associations between xenobiotic
activity and semen quantity and quality, even
though some misclassiﬁcation on both expo-
sure and outcome may appear. However, the
statistical power to detect effects on semen
quality within populations may be limited,
particularly for sperm concentration, which is
known to show considerable intra- and
interindividual variation (Bonde et al. 1996). 
If subfertile men with low or high receptor
activities were selectively declining to partici-
pate, the ﬁndings would be biased. Although
the participation rate was low in three of the
four regions, selection bias is unlikely, because
the men had no knowledge about either
semen quality or xenobiotic serum receptor
activity. Furthermore, the data did not indi-
cate markedly different associations in the
study group from Greenland, where the par-
ticipation rate was high compared with that of
the other study groups.
The ex vivo xenohormone assays have been
validated thoroughly (Bonefeld-Jorgensen
et al. 2006; Hjelmborg et al. 2006; Krüger
et al. 2007) and because no consistent associa-
tions between xenohormone activity and nat-
ural estrogen or testosterone levels were found,
it is unlikely that the xenohormone activities
were inﬂuenced by contamination of endoge-
nous steroid hormones (Bonefeld-Jorgensen
et al. 2006; Hjelmborg et al. 2006; Krüger
et al. 2007).
Negative ﬁndings may be biologically plau-
sible because most xenobiotic hormonal
actions of single compounds are weak in com-
parison with endogenous hormones (Safe
2000; Sharpe and Irvine 2004). In the present
study, the median estimated estrogen equiva-
lents (XER-EEQ) among subjects with agonis-
tic estrogenic serum activity (13%) was on
average 0.7 pg/mL serum, which is 4% of the
median estradiol value (19 pg/mL) measured
in the males in the present project (Giwercman
et al. 2006). Only about 2% of the total estra-
diol in men is free and not bound to sex
hormone–binding globulin (SHBG) or albu-
min (Van Pottelbergh et al. 2004), whereas
xenohormones can bind to SHBG or albumin
with much lower affinity, and therefore are
bioavailable to a larger extent (Crain et al.
1998). A more direct measure of the response
of the xenoestrogens can be seen as the further
increase in the XERcomp assay, which has
been determined to be 21% (Bonefeld-
Jorgensen et al. 2006). The activity of xenoe-
strogens is thus considerable, but also the
natural variation of estrogen level among men
is high (Giwercman et al. 2006), so it is likely
that the homeostatic processes of the body can
compensate for these changes in estrogenic
activity, and the production and maturation of
sperms will not be affected. However, the
xenobiotic serum estrogenicity was in the per-
centage range of physiologic levels in males and
far higher than expected when considering the
measured concentrations and the weak estro-
genic potency of individual POPs—some ﬁve
to six orders of magnitude lower than
17β-estradiol (Bolger et al. 1998). Because
only the serum fraction including the POPs
and not containing endogenous estrogens was
used for the analysis, this may indicate that
mixtures of several estrogenic compounds may
cause actions much higher than simple sum-
mation of effects (Rajapakse et al. 2002).
In conclusion, in the present study we
found that ex vivo estrogenic, androgenic, or
dioxin-like activity in serum samples from the
general population in Europe and among Inuits
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Figure 1. Sperm concentration (A) and sperm motility (B) in relation to XER activity in the four populations.
Reference value = 3.14.
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was not consistently and strongly associated
with adult semen quality. Future analysis
should investigate whether disturbances of fetal
ER, AR, or AhR activity cause more severe
reproductive effects. 
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